McKesson Corporation: A Defensive Healthcare Value Stock Without A Patent Cliff
Healthcare is a great defensive sector that has lower amounts of cyclicality than others that depend on the booming economy. With the stock currently down -21.44% off of its all-time high, the stock is giving investors a nice entry point as it reverts to the mean S&P500 returns. The company was the highest-scoring large cap on the most recent Magic Formula screen for October 2024.
McKesson (MCK) Stock Dips While Market Gains: Key Facts
McKesson (MCK) reachead $488.78 at the closing of the latest trading day, reflecting a -1.95% change compared to its last close.
Here's Why McKesson (MCK) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson (MCK) Stock Sinks As Market Gains: Here's Why
The latest trading day saw McKesson (MCK) settling at $479.06, representing a -0.02% change from its previous close.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Stock Of The Day: Has McKesson Found Its Bottom And Will It Bounce Back?
The best traders traders focus on key price levels and stock momentum, understanding that oversold stocks at support often experience a rally.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, McKesson (MCK) closed at $508.16, marking a -0.68% move from the previous day.
Here's Why You Should Retain McKesson Stock in Your Portfolio Now
MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson - Meet The New Dividend Stock On My Watchlist
McKesson's recent sell-off offers a compelling opportunity, driven by its strong position in healthcare distribution and growing focus on AI and technology for sustainable growth. The company boasts solid revenue and EPS growth, supported by AI integration, expansion into high-demand sectors like GLP-1 and oncology, and a robust business model. Shareholder returns are enhanced by aggressive buyback plans, a 15% dividend hike, and a healthy balance sheet, despite a low 0.6% dividend yield.
McKesson (MCK) Exceeds Market Returns: Some Facts to Consider
McKesson (MCK) reachead $518.81 at the closing of the latest trading day, reflecting a +1.49% change compared to its last close.
McKesson (MCK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
McKesson (MCK) concluded the recent trading session at $511.17, signifying a +0.14% move from its prior day's close.
